BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Wyeth Consumer Healthcare (WYE) Names New Head of Global R&D


2/18/2008 6:56:03 AM

MADISON, N.J., Feb. 15 /PRNewswire-FirstCall/ -- Wyeth Consumer Healthcare, a division of Wyeth , today announced that Isma Benattia, MD, has been named Executive Vice President, Global Research and Development (R&D), effective immediately. Dr. Benattia will lead all aspects of the consumer division's global R&D organization. In her new role, she will drive and prioritize the division's R&D efforts to effectively bring new products to market and manage the regulatory environment for Wyeth's over-the- counter products.

Dr. Benattia joins Wyeth Consumer Healthcare after serving at Wyeth Pharmaceuticals since 2003, where she most recently was Vice President, Global Labeling. During her time at Wyeth Pharmaceuticals, she also held the position of Executive Medical Director, Neuroscience, where she played a leading role in managing scientific and regulatory issues involving Effexor(R), Wyeth's second largest brand in terms of global revenue.

Prior to joining Wyeth, Dr. Benattia led global clinical programs for major products at Pfizer and Eli Lilly. Prior to joining the pharmaceutical industry, she was a practicing psychiatrist at the Pitie-Salpetriere and Bobigny University Hospitals in Paris.

Dr. Benattia holds master's degrees in Pharmacology and Psychotropic Drugs (Paris IX University); Methodology of Clinical Research (Paris XI Lariboisiere University); and Medical and Marketing Management (Paris XIII University). She earned her medical degree and Board Certification in Psychiatry from the University of Algiers and has been widely published in leading psychiatric journals.

Wyeth is one of the world's largest research-driven pharmaceutical and health care products companies. It is a leader in the discovery, development, manufacturing and marketing of pharmaceuticals, vaccines, biotechnology products and non-prescription medicines that improve the quality of life for people worldwide. The Company's major divisions include Wyeth Pharmaceuticals, Wyeth Consumer Healthcare and Fort Dodge Animal Health.

CONTACT: Media, Douglas Petkus, +1-973-660-5218, or Investors, Justin
Victoria, +1-973-660-5340, both of Wyeth

Web site: http://www.wyeth.com//


Read at BioSpace.com


   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->